![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-widens-probe-mdma-based-drug-studies-wsj-reports-2024-08-23/
https://www.reuters.com/business/healthcare-pharmaceuticals/lykos-cuts-workforce-by-75-2024-08-15/
https://www.prnewswire.com/news-releases/lykos-therapeutics-announces-reorganization-to-address-fdas-recent-decision-on-midomafetamine-capsules-for-ptsd-302223812.html
https://www.fiercebiotech.com/biotech/one-two-punch-lykos-three-articles-mdma-treatment-retracted-due-unethical-conduct
https://www.globenewswire.com/news-release/2024/08/10/2927986/0/en/MAPS-Statement-on-FDA-Complete-Response-Letter-for-MDMA-Assisted-Therapy-for-PTSD-New-Drug-Application.html
https://www.globenewswire.com/news-release/2024/08/09/2927964/0/en/PharmAla-Comments-on-USFDA-Decision-regarding-MDMA-Assisted-Therapy-and-Announces-Patent-Granting-for-ALA-002.html
https://endpts.com/lykos-takes-another-hit-as-icer-lays-out-insufficient-evidence-for-mdma-based-treatment/
https://www.fiercebiotech.com/biotech/mdma-debate-spreading-beyond-biotech-lykos-ceo-tries-dispel-efficacy-safety-concerns
https://www.biopharmadive.com/news/mdma-psychedelic-drug-development-hurdles-fda-panel-vote/718290/
https://www.reuters.com/business/healthcare-pharmaceuticals/fda-panel-review-psychedelic-drug-mdma-first-time-2024-06-04/